AMIT-Alfred Mann Institute

Focuses on early-stage medical technology and life science innovations, driving commercialization.

Last updated Jul 4, 2026

VC2 portfolioSan Jose, Israel

About

The Alfred Mann Institute (AMI) is dedicated to fostering and commercializing groundbreaking medical technologies. They invest in and support early-stage companies with a strong scientific foundation, aiming to translate innovative research into impactful healthcare solutions.

Key facts

Website: almann.org
Type: VC
Headquarters: San Jose, Israel
Portfolio companies: 2
Stages: Seed
Cheque size: $650K to $3M
Sector focus: Healthcare
Medical Imaging
Ultrasound
Nanotechnology
Biotech

Recent investments

Recent funding rounds AMIT-Alfred Mann Institute took part in
Date	Company	Round	Amount
30 Apr 2019	TechsoMed	Seed	$3M
1 Jan 2017	Nurami Medical	Seed	$650K

Add first review

Frequently asked

What companies has AMIT-Alfred Mann Institute invested in?

AMIT-Alfred Mann Institute has invested in TechsoMed, Nurami Medical.

Public record

SEC filings, insider activity, nonprofit links and pay benchmarks for AMIT-Alfred Mann Institute